Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine as Adjuvant to Iron Chelation in Thalassemia
NCT02474420Unknown
- Start
- Jun 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of amlodipine in iron overload cardiomyopathy (IOC) (2 arms). Primary endpoint: Change in cardiac T2* at 12 months. Status: unknown.
02
Drugs
amlodipine
03
Conditions
iron overload cardiomyopathy (IOC)
Beyond the preview
Go deeper on NCT02474420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02474420.